Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04417998 · ClinicalTrials.gov registry record · Phase 4
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT04417998: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT04417998 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04417998, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of new software available on a new PET/CT scanner in the Molecular Imaging Research PET/CT Facility. Further, the study aims to evaluate the data acquisition and image processing workflow.
Interventions
- DRUG 18F-FDG
- DRUG 18F-AV1451
- DEVICE Siemens E7 Reconstruction Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-06-03 |
| Est. Completion | 2023-12-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04417998
The ClinicalTrials.gov registry entry for NCT04417998 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 18F-FDG is the first listed.
NCT04417998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04417998 about?
NCT04417998 is a clinical study titled "Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction". The purpose of this study is to assess the effectiveness of new software available on a new PET/CT scanner in the Molecular Imaging Research PET/CT Facility. Further, the study aims to evaluate the data acquisition and image processing workflow.
What is the current status of trial NCT04417998?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2020-06-03. Estimated completion is 2023-12-20.
What interventions are being tested in trial NCT04417998?
The interventions under investigation include: 18F-FDG (DRUG), 18F-AV1451 (DRUG), Siemens E7 Reconstruction Tool (DEVICE).
Who is sponsoring clinical trial NCT04417998?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.